Tejnaksh Healthcare Share Price | Tejnaksh Healthcare Stock Screener
TEJNAKSH
Healthcare Service Provider
Share Price BSE
₹14.25
▲
0.59 (4.32%)
As of July 24, 2026, the Tejnaksh Healthcare share price (BSE: TEJNAKSH) is ₹14.25, up 4.32% from the previous close, with shares trading between ₹13.55 and ₹14.30, and a 52-week range of ₹11.18–₹19.59.
Analyse Tejnaksh Healthcare stock price data download and track historical price performance.
Use the Tejnaksh Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Tejnaksh Healthcare Market Cap
₹29.45 Cr.
TEJNAKSH P/E Ratio (TTM)
24.62
Tejnaksh Healthcare P/B Ratio
1.07
EPS (TTM)
₹0.61
Dividend Yield
-
Debt to Equity
0.12
TEJNAKSH 52 Week High
₹19.59
Tejnaksh Healthcare 52 Week Low
₹11.18
Operating Margin
28.00%
Profit Margin
-
TEJNAKSH Revenue (TTM)
₹3.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹30.00
Total Equity
₹27.00
Tejnaksh Healthcare Share Price Chart
Screen Tejnaksh Healthcare share price with an interactive chart. Analyse TEJNAKSH price trends and volatility across different timeframes.
Tejnaksh Healthcare Company Profile - Fundamental Screener
Screen Tejnaksh Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for TEJNAKSH shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE030T01027
Tejnaksh Healthcare Balance Sheet Screener
Screen TEJNAKSH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 30 | 30 | 31 | 31 | 30 | 25 | 25 | 22 | 20 | 16 |
| Current Assets | 5 | 6 | 6 | 6 | 5 | 3 | 7 | 5 | 3 | 2 |
| Fixed Assets | 20 | 21 | 23 | 23 | 15 | 15 | 17 | 17 | 15 | 14 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 3 | 6 | 7 | 7 | 5 | 8 | 6 | 6 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 27 | 27 | 24 | 22 | 21 | 18 | 16 | 14 | 10 | 8 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 2 | 2 |
| Reserves & Surplus | 17 | 16 | 13 | 12 | 10 | 7 | 5 | 3 | 8 | 6 |
Tejnaksh Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Tejnaksh Healthcare income statement and profit fundamentals.
Analyze TEJNAKSH quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Tejnaksh Healthcare share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Expenses | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 28.00% | 22.00% | 23.00% | 26.00% | 26.00% | 31.00% | 34.00% | 34.00% | 36.00% | 14.00% | 17.00% | 37.00% | 34.00% | 37.00% | 38.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
| EPS | 0.17 | 0.21 | 0.12 | 0.15 | 0.14 | 0.25 | 0.29 | 0.31 | 0.38 | -0.01 | 0.08 | 0.28 | 0.27 | 0.53 | 0.55 |
Tejnaksh Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen TEJNAKSH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 4 | 2 | 9 | 1 | 1 | 3 | 5 | 2 | 4 |
| Investing Activities | 4 | -1 | -1 | -11 | 2 | -1 | -2 | -3 | -8 | -3 |
| Financing Activities | -4 | -2 | -1 | 2 | -3 | 0 | -2 | -1 | 6 | 0 |
| Net Cash Flow | 0 | 1 | -1 | 0 | 0 | 0 | -1 | 1 | 1 | 0 |
Tejnaksh Healthcare Shareholding Pattern Screener
See Tejnaksh Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Tejnaksh Healthcare promoter holding and ownership changes for TEJNAKSH on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.28% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.58% | 23.58% | 23.60% | 23.73% | 23.72% | 22.21% | 23.49% | 23.84% |
| Other Holding | 2.59% | 2.58% | 2.57% | 2.44% | 2.44% | 3.68% | 2.68% | 2.33% |
| Shareholder Count | 4,414 | 4,493 | 4,552 | 4,550 | 4,452 | 3,502 | 3,776 | 4,067 |
Tejnaksh Healthcare Share Dividend Screener - Share Yield Analysis
Check Tejnaksh Healthcare dividend history with payout and yield data.
View Tejnaksh Healthcare dividend details including ex-dates and amounts for TEJNAKSH stock.
Tejnaksh Healthcare Stock Index Membership
See which indices include Tejnaksh Healthcare stock.
Check TEJNAKSH index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Tejnaksh Healthcare Market Events Screener - Corporate Actions
Get Tejnaksh Healthcare corporate actions including splits, bonuses, and buybacks.
Check Tejnaksh Healthcare stock events that may affect TEJNAKSH share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 9.73% |
| 2026-02-07 | 2026-02-07 | Quarterly Result Announcement | NA | 6.30% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -1.66% |
| 2025-09-27 | 2025-09-27 | Annual General Meeting | NA | -1.62% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -1.77% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.72% |
| 2025-02-22 | 2025-02-22 | Extraordinary General Meeting | NA | -2.79% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -0.42% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.42% |
| 2024-09-28 | 2024-09-28 | Annual General Meeting | NA | -1.20% |
| 2023-07-19 | 2023-05-20 | Split | 5:10 | 0.00% |
| 2018-04-26 | 2018-04-28 | Bonus | 36:10 | 25.55% |
Tejnaksh Healthcare Competitors Screener - Peer Comparison
Screen TEJNAKSH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 28,500 | 55.73 | 2,864 | 12.11% | 510 | 55.92 |
| Vijaya Diagnostic Centre | 13,699 | 79.34 | 814 | 16.36% | 182 | 48.41 |
| Metropolis Healthcare | 11,793 | 62.17 | 1,646 | 22.25% | 185 | 55.17 |
| Thyrocare Technologies | 8,959 | 54.28 | 846 | 20.48% | 163 | 59.90 |
| Nephrocare Health Services | 6,286 | 82.61 | 999 | 29.74% | 62 | 39.12 |
| Krsnaa Diagnostics | 1,792 | 17.41 | 773 | 4.05% | 106 | 51.75 |
| Suraksha Diagnostic | 1,359 | 42.71 | 310 | 21.30% | 34 | 41.17 |
| One Global Service Provider | 1,182 | 16.75 | 498 | 237.06% | 69 | 48.61 |
| 3B BlackBio DX | 1,092 | 18.00 | 142 | 27.17% | 61 | 58.62 |
| Health X Platform | 1,012 | -707.89 | 1,319 | 12.68% | -3 | 50.95 |
Tejnaksh Healthcare Company Announcements - News Screener
Screen TEJNAKSH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-25 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-30 | Submission Of Audited Financial Results (Standalone & Consolidated) For The Quarter Ended And Year End On 31St March 2026. | - |
| 2026-05-30 | Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Disclosure Pursuant To Regulation 30. | - |
| 2026-05-20 | Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 | - |
| 2026-04-28 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-21 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-09 | Reply To The Clarification Sought By The Stock Exchange With Reference To The Significant Movement In Share Price Of The Securities Of The Company; | - |
| 2026-04-08 | Clarification sought from Tejnaksh Healthcare Ltd | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-02-07 | Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 31St December 2025. | - |
| 2026-02-07 | Board Meeting Outcome for Outcome Of Board Meeting In_Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Held On 7Th Feb 2026 | - |
| 2026-02-02 | Board Meeting Intimation for 1. To Consider And Approve Un-Audited Financial Results (Standalone & Consolidated) For The Quarter 31St December 2025. 2. Any Other Matter With The Permission Of The Chair. | - |
| 2026-01-18 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-28 | Closure of Trading Window | - |
| 2025-11-08 | Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2025 | - |
| 2025-11-08 | Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2025-11-02 | Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure Of Trading Window | - |
| 2025-10-19 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |